BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui YN, Xu QX, Davoodi P, Wang DP, Wang CH. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Acta Pharmacol Sin 2017;38:943-53. [PMID: 28552909 DOI: 10.1038/aps.2017.45] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Bajracharya R, Song JG, Patil BR, Lee SH, Noh HM, Kim DH, Kim GL, Seo SH, Park JW, Jeong SH, Lee CH, Han HK. Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems. Drug Deliv 2022;29:1959-70. [PMID: 35762636 DOI: 10.1080/10717544.2022.2089296] [Reference Citation Analysis]
2 Sokol MB, Yabbarov NG, Mollaeva MR, Chirkina MV, Mollaev MD, Zabolotsky AI, Kuznetsov SL, Nikolskaya ED. Alpha-fetoprotein mediated targeting of polymeric nanoparticles to treat solid tumors. Nanomedicine (Lond) 2022. [PMID: 36136593 DOI: 10.2217/nnm-2022-0097] [Reference Citation Analysis]
3 Liu Y, Guo K, Ding M, Zhang B, Xiao N, Tang Z, Wang Z, Zhang C, Shubhra QTH. Engineered Magnetic Polymer Nanoparticles Can Ameliorate Breast Cancer Treatment Inducing Pyroptosis-Starvation along with Chemotherapy. ACS Appl Mater Interfaces 2022. [PMID: 36094305 DOI: 10.1021/acsami.2c13011] [Reference Citation Analysis]
4 Alhaj-suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114482] [Reference Citation Analysis]
5 Singh AP, Prakash O, Kumar S, Shukla A, Maiti P. Poly(lactic acid-co-glycolic acid) as sustained drug delivery vehicle for melanoma therapy. Materials Today Communications 2022;31:103661. [DOI: 10.1016/j.mtcomm.2022.103661] [Reference Citation Analysis]
6 Talaśka K, Wojtkowiak D, Wilczyński D, Ferreira A. Computational methodology for drug delivery to the inner ear using magnetic nanoparticle aggregates. Computer Methods and Programs in Biomedicine 2022;221:106860. [DOI: 10.1016/j.cmpb.2022.106860] [Reference Citation Analysis]
7 Quadir SS, Saharan V, Choudhary D, Harish, Jain CP, Joshi G. Nano-strategies as Oral Drug Delivery Platforms for Treatment of Cancer: Challenges and Future Perspectives. AAPS PharmSciTech 2022;23:152. [PMID: 35606661 DOI: 10.1208/s12249-022-02301-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ibrahim A, Khalil IA, El-Sherbiny IM. Development and evaluation of core-shell nanocarrier system for enhancing the cytotoxicity of doxorubicin/ metformin combination against breast cancer cell line. J Pharm Sci 2022:S0022-3549(22)00213-1. [PMID: 35613685 DOI: 10.1016/j.xphs.2022.05.018] [Reference Citation Analysis]
9 Liu Y, Ding M, Guo K, Wang Z, Zhang C, Shubhra QT. Systemic Co-delivery of drugs by a pH- and photosensitive smart nanocarrier to treat cancer by chemo-photothermal-starvation combination therapy. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Aldawsari HM, Singh S, Alhakamy NA, Bakhaidar RB, Halwani AA, Sreeharsha N, Badr-eldin SM. Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer. Pharmaceuticals 2022;15:544. [DOI: 10.3390/ph15050544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Khan MI, Hossain MI, Hossain MK, Rubel MHK, Hossain KM, Mahfuz AMUB, Anik MI. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review. ACS Appl Bio Mater 2022. [PMID: 35226465 DOI: 10.1021/acsabm.2c00002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
12 Rehman MU, Khan A, Imtiyaz Z, Ali S, Makeen HA, Rashid S, Arafah A. Current Nano-therapeutic Approaches Ameliorating Inflammation in Cancer Progression. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 El-hammadi MM, Arias JL. Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines. Nanomaterials 2022;12:354. [DOI: 10.3390/nano12030354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sartaj A, Qamar Z, Qizilbash FF, Annu, Md S, Alhakamy NA, Baboota S, Ali J. Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations. Polymers (Basel) 2021;13:4400. [PMID: 34960948 DOI: 10.3390/polym13244400] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
15 Md S, Alhakamy NA, Neamatallah T, Alshehri S, Mujtaba MA, Riadi Y, Radhakrishnan AK, Khalilullah H, Gupta M, Akhter MH. Development, Characterization, and Evaluation of α-Mangostin-Loaded Polymeric Nanoparticle Gel for Topical Therapy in Skin Cancer. Gels 2021;7:230. [PMID: 34842729 DOI: 10.3390/gels7040230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Hwang SR, Chakraborty K, An JM, Mondal J, Yoon HY, Lee YK. Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy. Pharmaceutics 2021;13:1875. [PMID: 34834290 DOI: 10.3390/pharmaceutics13111875] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Jiang G, Huang Z, Yuan Y, Tao K, Feng W. Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells. J Hematol Oncol 2021;14:139. [PMID: 34488814 DOI: 10.1186/s13045-021-01150-x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Shubhra QTH, Guo K, Liu Y, Razzak M, Serajum Manir M, Moshiul Alam AKM. Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity. Acta Biomater 2021;131:493-507. [PMID: 34139367 DOI: 10.1016/j.actbio.2021.06.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
19 Fernández-Álvarez F, García-García G, Arias JL. A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer. Pharmaceutics 2021;13:1232. [PMID: 34452193 DOI: 10.3390/pharmaceutics13081232] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Dhas N, Kudarha R, Pandey A, Nikam AN, Sharma S, Singh A, Garkal A, Hariharan K, Singh A, Bangar P, Yadhav D, Parikh D, Sawant K, Mutalik S, Garg N, Mehta T. Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: Conjugation chemistry and alternative therapeutic strategies. Journal of Controlled Release 2021;333:188-245. [DOI: 10.1016/j.jconrel.2021.03.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
21 Koneru T, McCord E, Pawar S, Tatiparti K, Sau S, Iyer AK. Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas. ACS Omega 2021;6:8727-33. [PMID: 33842744 DOI: 10.1021/acsomega.0c05848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
22 Takke A, Shende P. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer. Life Sci 2021;275:119377. [PMID: 33757771 DOI: 10.1016/j.lfs.2021.119377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rojas-Prats E, Tosat-Bitrián C, Martínez-González L, Nozal V, Pérez DI, Martínez A. Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. Pharmaceutics 2021;13:180. [PMID: 33525757 DOI: 10.3390/pharmaceutics13020180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Fernández-Álvarez F, Caro C, García-García G, García-Martín ML, Arias JL. Engineering of stealth (maghemite/PLGA)/chitosan (core/shell)/shell nanocomposites with potential applications for combined MRI and hyperthermia against cancer. J Mater Chem B 2021;9:4963-80. [PMID: 34114575 DOI: 10.1039/d1tb00354b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci 2020;7:193. [PMID: 32974385 DOI: 10.3389/fmolb.2020.00193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 112] [Article Influence: 11.0] [Reference Citation Analysis]
26 Guan S, Zhang Q, Bao J, Hu R, Czech T, Tang J. Recognition Sites for Cancer-targeting Drug Delivery Systems. Curr Drug Metab 2019;20:815-34. [PMID: 31580248 DOI: 10.2174/1389200220666191003161114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Chivere VT, Kondiah PPD, Choonara YE, Pillay V. Nanotechnology-Based Biopolymeric Oral Delivery Platforms for Advanced Cancer Treatment. Cancers (Basel) 2020;12:E522. [PMID: 32102429 DOI: 10.3390/cancers12020522] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
28 Popescu RC, Andronescu E, Vasile BS. Recent Advances in Magnetite Nanoparticle Functionalization for Nanomedicine. Nanomaterials (Basel) 2019;9:E1791. [PMID: 31888236 DOI: 10.3390/nano9121791] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
29 Rençber S, Aydın Köse F, Karavana SY. Dexamethasone loaded PLGA nanoparticles for potential local treatment of oral precancerous lesions. Pharmaceutical Development and Technology 2020;25:149-58. [DOI: 10.1080/10837450.2019.1673407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
30 Jose S, A CT, Sebastian R, H SM, A AN, Durazzo A, Lucarini M, Santini A, Souto EB. Transferrin-Conjugated Docetaxel-PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle. Polymers (Basel) 2019;11:E1905. [PMID: 31752417 DOI: 10.3390/polym11111905] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
31 Grumezescu V, Gherasim O, Negut I, Banita S, Holban AM, Florian P, Icriverzi M, Socol G. Nanomagnetite-embedded PLGA Spheres for Multipurpose Medical Applications. Materials (Basel) 2019;12:E2521. [PMID: 31398805 DOI: 10.3390/ma12162521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Taghipour-sabzevar V, Sharifi T, Moghaddam MM. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents. Therapeutic Delivery 2019;10:527-50. [DOI: 10.4155/tde-2019-0044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
33 Liang J, Huang Q, Hua C, Hu J, Chen B, Wan J, Hu Z, Wang B. pH‐Responsive Nanoparticles Loaded with Graphene Quantum Dots and Doxorubicin for Intracellular Imaging, Drug Delivery and Efficient Cancer Therapy. ChemistrySelect 2019;4:6004-12. [DOI: 10.1002/slct.201803807] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
34 Bamburowicz-Klimkowska M, Poplawska M, Grudzinski IP. Nanocomposites as biomolecules delivery agents in nanomedicine. J Nanobiotechnology 2019;17:48. [PMID: 30943985 DOI: 10.1186/s12951-019-0479-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
35 You L, Liu X, Fang Z, Xu Q, Zhang Q. Synthesis of multifunctional Fe3O4@PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer. Mater Sci Eng C Mater Biol Appl 2019;94:291-302. [PMID: 30423711 DOI: 10.1016/j.msec.2018.09.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
36 Mehdi YA, Itatahine A, Fizir M, Xiao D, Dramou P, He H. Multifunctional core-shell silica microspheres and their performance in self-carrier decomposition, sustained drug release and fluorescent bioimaging. Journal of Solid State Chemistry 2018;263:148-56. [DOI: 10.1016/j.jssc.2018.04.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, Wang CH. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev 2018;132:104-38. [PMID: 30415656 DOI: 10.1016/j.addr.2018.07.002] [Cited by in Crossref: 137] [Cited by in F6Publishing: 120] [Article Influence: 34.3] [Reference Citation Analysis]
38 Borroni E, Miola M, Ferraris S, Ricci G, Žužek Rožman K, Kostevšek N, Catizone A, Rimondini L, Prat M, Verné E, Follenzi A. Tumor targeting by lentiviral vectors combined with magnetic nanoparticles in mice. Acta Biomater 2017;59:303-16. [PMID: 28688987 DOI: 10.1016/j.actbio.2017.07.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
39 Huang YZ, Li YP. Cancer nanobiotechnolgy. Acta Pharmacol Sin 2017;38:735-7. [PMID: 28569768 DOI: 10.1038/aps.2017.48] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]